Additionally, other studies have found an elevated risk of thyroid cancer in GLP-1RA users (odds ratio 1.58), further emphasizing the need for careful patient selection
Oral alternatives Oral GLP-1 formulations are emerging as alternatives to injection
Lets look closer at two of those: changes in hormones (think menopause) and popular medications like GLP-1s (such as semaglutide or tirzepatide)
These include gastrointestinal issues (nausea, vomiting, diarrhea, constipation), pancreatitis, thyroid tumors, gallstones, hair loss, and mental health concerns
Potentiation of glucose-stimulated insulin release from pancreatic beta cells embodies the classic incretin action, reducing postprandial hyperglycemia and chronic hyperinsulinemia [35,36]
Understanding how long GLP-1 approaches take to start working helps set realistic expectations for any method you choose